NEOPAL: A randomized phase II study comparing RCB response to neoadjuvant chemotherapy or letrozole-palbociclib in PAM50 defined postmenopausal luminal breast cancer

Cottu, Paul;Duhoux, François;Lemonnier, Jréôme;Bonnefoi, Hervé;Delaloge, Suzette;et.al.
(2014) San Antonio Breast Cancer Symposium (SABCS) — Location: San Antonio, TX, USA (12.December.2014)

Files

No attached file found for this publication.

Details

Authors
  • Cottu, PaulInstitut Curie, Paris, France
    Author
  • Duhoux, Françoisorcid-logoUCLouvain
    Author
  • Lemonnier, JréômeUnicancer, Paris, France
    Author
  • Bonnefoi, HervéInstitut Bergonié, Bordeaux, France
    Author
  • Asselain, BernardUCLouvain
    Author
  • Delaloge, SuzetteInstitut Gustave Roussy, Villejuif, France
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Cottu, P., Duhoux, F., Lemonnier, J., Bonnefoi, H., Vincent Salomon, A., Asselain, B., & Delaloge, S. (2014). NEOPAL: A randomized phase II study comparing RCB response to neoadjuvant chemotherapy or letrozole-palbociclib in PAM50 defined postmenopausal luminal breast cancer. Cancer Research, 75(9), suppl. https://hdl.handle.net/2078.5/92475 (Original work published 2015)